SEC 13F Intelligence

Notable Investors / Q1 2026

Samantha McLemore’s Portfolio — Patient Capital Management, LLC

Founder & CIO, Patient Capital Management

CIK 0001854794 · ONE SOUTH STREET, SUITE 2101, BALTIMORE, MD, 21202 · 410-454-3130

About Samantha McLemore

Samantha McLemore, Bill Miller's longtime co-manager on the Opportunity Trust, founded Patient Capital Management to continue the strategy independently: contrarian, valuation-driven positions held through drawdowns most managers can't stomach.

Patient Capital's 13F features the strategy's signature mix — mega-cap platforms the market briefly hates, travel and consumer cyclicals bought in panics, and selected crypto-adjacent equities.

Portfolio data below is from Patient Capital Management, LLC’s SEC 13F filings. View the full filer page →

Reported Value
$2.7B
Q1 2026
Positions
40
Filings on Record
18
2019–present window
Filed
May 14, 2026
original filing

Summary

Patient Capital Management, LLC reported $2.7B in U.S.-listed holdings across 40 positions for Q1 2026.

Its largest position, Royalty Pharma, represents 6.4% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+48.7%
share of reported value
Largest Position
+6.4%
Royalty Pharma

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $347MQ4 ’21Q1 ’22: $295MQ2 ’22: $226MQ3 ’22: $200MQ3 ’22Q4 ’22: $206MQ1 ’23: $224MQ2 ’23: $1.8BQ2 ’23Q3 ’23: $1.7BQ4 ’23: $1.9BQ1 ’24: $2.1BQ1 ’24Q2 ’24: $1.9BQ3 ’24: $2.0BQ4 ’24: $2.2BQ4 ’24Q1 ’25: $1.9BQ2 ’25: $2.2BQ3 ’25: $2.5BQ3 ’25Q4 ’25: $2.6BQ1 ’26: $2.7Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 71.8%Other: 20.0%MLP: 4.3%ETP: 2.3%ADR: 1.5%
  • Common Stock · 71.8% · $2.0B
  • Other · 20.0% · $548M
  • MLP · 4.3% · $118M
  • ETP · 2.3% · $64M
  • ADR · 1.5% · $41M

Quarter-over-Quarter Changes full breakdown →

Holdings — Q1 2026

38 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ROYALTY PHARMA PLCSHS CLASS A6.39%$175M3.64M
2TRVCCITIGROUP INChistory →COM NEW5.86%$160M1.41M
3GOOGLALPHABET INChistory →CAP STK CL A5.61%$154M534.0K
4AMZNAMAZON COM INChistory →COM4.98%$136M654.4K
5QXOQXO INChistory →COM NEW4.81%$132M6.78M
6NVDANVIDIA CORPORATIONhistory →COM4.53%$124M711.1K
7UNHUNITEDHEALTH GROUP INChistory →COM4.32%$118M437.1K
8ETENERGY TRANSFER L Phistory →COM UT LTD PTN4.30%$118M6.09M
90J7QIAC INChistory →COM NEW3.95%$108M2.70M
10NORWEGIAN CRUISE LINE HLDGSSHS3.93%$108M5.75M
11SEADRILL LTDCOM3.58%$98M2.15M
12METAMETA PLATFORMS INChistory →CL A3.58%$98M171.1K
13CVSCVS HEALTH CORPhistory →COM3.56%$97M1.36M
14COINCOINBASE GLOBAL INChistory →COM CL A2.75%$75M430.4K
15ADBEADOBE INChistory →COM2.64%$72M297.3K
16CROXCROCS INChistory →COM2.56%$70M842.8K
17BIIBBIOGEN INChistory →COM2.55%$70M379.7K
18PGENPRECIGEN INChistory →COM2.52%$69M17.82M
19UALUNITED AIRLS HLDGS INChistory →COM2.46%$67M732.0K
20ILMNILLUMINA INChistory →COM2.46%$67M544.8K
21NOBLE CORP PLCORD SHS A2.42%$66M1.35M
22GMGENERAL MTRS COhistory →COM2.03%$55M744.6K
23FISVFISERV INChistory →COM1.98%$54M968.2K
24CHYMCHIME FINL INChistory →COM SHS CL A1.97%$54M2.88M
25UBS GROUP AGSHS1.77%$49M1.24M
26IBITISHARES BITCOIN TRUST ETFhistory →SHS BEN INT1.55%$42M1.10M
27OMFONEMAIN HLDGS INChistory →COM1.53%$42M781.4K
28JDJD.COM INChistory →SPON ADS CL A1.51%$41M1.40M
29EXPEEXPEDIA GROUP INChistory →COM NEW1.42%$39M167.8K
30DALDELTA AIR LINES INChistory →COM NEW1.34%$37M552.5K
31SOFISOFI TECHNOLOGIES INChistory →COM0.77%$21M1.33M
32FBTCFIDELITY WISE ORIGIN BITCOINhistory →SHS0.76%$21M353.8K
33TEMTEMPUS AI INChistory →CL A0.73%$20M442.2K
34PLAYDAVE & BUSTERS ENTMT INChistory →COM0.46%$12M1.15M
35JPMJPMORGAN CHASE & COhistory →COM0.32%$9M29.4K
36APAAPA CORPORATIONhistory →COM0.08%$2M50.0K
37LEN/BLENNAR CORPhistory →CL B0.04%$1M12.5K
38STATE STR SPDR S&P 500 ETF TTR UNIT0.03%$725,5711.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$2.7B40May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$2.6B40Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$2.5B41Oct 30, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.2B40Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.9B39May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.2B43Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.0B41Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.9B40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.1B42May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.9B43Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.7B42Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.8B44Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$224M42May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$206M43Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$200M42Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$226M42Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$295M45May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$347M43Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.